Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Red Blood Cells Function as Critical Immune Sensors by Binding Cell-Free DNA

By LabMedica International staff writers
Posted on 04 Nov 2021
Red blood cells (RBCs) are essential for aerobic respiration through delivery of oxygen to distant tissues. More...
However, RBCs are currently considered immunologically inert, and few, if any, secondary functions of RBCs have been identified.

Although non–gas exchanging functions of the red cell such as chemokine regulation, complement binding, and pathogen immobilization have been described, RBC immune function remains enigmatic. RBCs transit through all tissues and contact pathogen and self-derived inflammatory mediators in the circulation, positioning them as ideal messengers between distant organs.

A large team of Clinical Scientists led by those at the University of Pennsylvania School of Medicine (Philadelphia, PA, USA) examined the red blood cells of about 50 sepsis patients and 100 COVID-19 patients and found that, during these illnesses, red blood cells express an increased amount of the specific Toll-like receptors (TLR) protein called TLR9 on their surface. TLRs are a class of proteins that play a key role in the immune system by activating immune responses like cytokine production. Hemoglobin parameters were collected from the electronic medical record complete blood count on days 0 and 7, selecting the lowest value from the day if more than one measurement was available per day.

The investigators showed that when the red blood cells bind too much inflammation-causing nucleic acid, they lose their normal structure, causing the body to not recognize them anymore. This leads to erythrophagocytosis by splenic macrophages, resulting in acute anemia. When this happens it causes the immune system to become activated in otherwise unaffected organs, creating inflammation. This mechanistic discovery opens the door to studies on how to block this specific receptor and create targeted therapies for autoimmune diseases, infectious diseases, and a whole host of inflammatory illnesses associated with acute anemia.

The detection and capture of nucleic acid by TLR9-expressing RBCs regulated red cell clearance and inflammatory cytokine production, demonstrating that RBCs function as immune sentinels during pathologic states. Consistent with these findings, RBC-bound mitochondrial DNA was elevated in individuals with viral pneumonia and sepsis secondary to coronavirus disease 2019 (COVID-19) and associated with anemia and severity of disease.

Nilam Mangalmurti, MD, an assistant professor and senior author of the study, said, “Anemia is common, affecting about a quarter of the world’s population. Acute inflammatory anemia is often seen early after an infection such as parasitic infections that cause malaria. For a long time we haven’t known why people, when they are critically ill from sepsis, trauma, COVID-19, a bacterial infection, or parasite infection, develop an acute anemia. These findings explain one of the mechanisms for the development of acute inflammatory anemia for the first time.”

The authors concluded that they had demonstrated that RBCs serve as DNA sensors through surface expression of TLR9, which appears to be beneficial during quiescent states, where it promotes scavenging of trace CpG to prevent nonspecific inflammation. However, during conditions characterized by excess circulating CpG, such as sepsis and COVID-19, binding of CpG by RBC-TLR9 leads to accelerated clearance and inflammation. The study was published on October 20, 2021 in the journal Science Translational Medicine.

Related Links:
University of Pennsylvania School of Medicine


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Serological Pipet Controller
PIPETBOY GENIUS
New
Sample Transportation System
Tempus1800 Necto
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.